<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We analyzed the prognostic value of clinical, hematologic and bone marrow (BM) histologic findings at presentation in 94 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) (28 RA; 2 RARS; 34 RAEB; 6 CMML; 24 RAEB-t) </plain></SENT>
<SENT sid="1" pm="."><plain>With survival as the dependent variable, stepwise multivariate analysis indicated as the prognostically most important factors among the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> taken as a whole: latency from the first symptoms to diagnosis, age, and percentage of BM blasts </plain></SENT>
<SENT sid="2" pm="."><plain>In each main <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> group the most unfavorable initial characteristics were: 1) low Hb, no macro-megaloblastosis, male sex for RA/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>; 2) low Hb and low platelet levels for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>; 3) granuloblastic <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> and high BM blastosis for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t </plain></SENT>
<SENT sid="3" pm="."><plain>Of the BM histologic parameters, only the percentage of blasts had significant prognostic value </plain></SENT>
<SENT sid="4" pm="."><plain>Histologic assessment of BM blastosis, however, did not differ statistically from that based on cytologic examination of BM smears, so that marrow histology seemed not essential for initial prognostic assessment in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="5" pm="."><plain>The finding of abnormal localization of immature precursors (ALIP) in BM biopsies was associated with a negative trend without reaching statistical significance </plain></SENT>
<SENT sid="6" pm="."><plain>Using four objective parameters of proven significance (age, Hb, platelets, and BM blasts) we devised a staging system of immediate clinical utility for prognostic stratification and risk-adapted therapeutic choices </plain></SENT>
</text></document>